Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (FRA:GU5)

FRA:GU5 Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 19.77B CNY in the quarter ending September 30, 2025, with 9.74% growth. This brings the company's revenue in the last twelve months to 77.54B, up 1.50% year-over-year. In the year 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 74.99B, down -0.69%.

• Revenue (ttm): 77.54B CNY
• Revenue Growth: +1.50%
• P/S Ratio: 0.53
• Revenue / Employee: 2.83M CNY
• Employees: 27,425
• Market Cap: 4.89B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	74.99B	-522.58M	-0.69%
Dec 31, 2023	75.52B	4.73B	6.68%
Dec 31, 2022	70.79B	1.77B	2.57%
Dec 31, 2021	69.01B	7.34B	11.90%
Dec 31, 2020	61.67B	-3.28B	-5.05%